Sequences of biological treatments for patients with moderate-to-severe rheumatoid arthritis in the era of treat-to-target in China: a cost-effectiveness analysis

2021 ◽  
Author(s):  
Chongqing Tan ◽  
Xia Luo ◽  
Sini Li ◽  
Lidan Yi ◽  
Xiaohui Zeng ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Cost Effectiveness ◽  
Cost Effectiveness Analysis ◽  
Treat To Target ◽  
Severe Rheumatoid Arthritis ◽  
Effectiveness Analysis ◽  
Biological Treatments

scholarly journals Cost-effectiveness analysis of baricitinib versus adalimumab for the treatment of moderate-to-severe rheumatoid arthritis in Spain

2019 ◽  
Vol Volume 11 ◽  
pp. 395-403 ◽  
Author(s):  
Max Schlueter ◽  
Elaine Finn ◽  
Silvia Díaz ◽  
Tatiana Dilla ◽  
José Inciarte-Mundo ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Cost Effectiveness ◽  
Cost Effectiveness Analysis ◽  
Severe Rheumatoid Arthritis ◽  
Effectiveness Analysis
Sign in / Sign up

Export Citation Format

Share Document